Executive Scientific Council of the 12th World Congress of Microcirculation held in Beijing, China in September of 2023.
Our laboratory's primary research areas include: exploring sex differences related to regenerative medicine in the heart, particularly in an aging model, developing cell-based therapies designed for a dysfunctional coronary microcirculation, and progressing adipose-derived tissue-engineering technology into pre-clinical research phases. The laboratory utilizes both in vivo and ex vivo models to evaluate cardiac and coronary vessel function (respectively), but also uses a wide variety of molecular biology approaches to evaluate specific changes in coronary signaling mechanisms as a result of ischemia and/or aging.
Copyright © 2024 LeBlanc Laboratory - All Rights Reserved.
Powered by GoDaddy